TRPV1 and ischemia: A TRPV1 antagonist, capsazepine (20 nmol), injected intracerebroventricularly 30 min before the onset of ischemia, attenuated neurological and motor deficits and decreased infarct size instead of influencing cerebral blood flow in the occluded MCA territory.